Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Oncoimmunology|October 6, 2018
WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapyLillian Sun, Ellen Moore, Rose Berman, et al.Oncotarget|September 17, 2017
Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cellsPaul E Clavijo, Ellen C Moore, Jianhong Chen, et al.Oncoimmunology|February 6, 2018
PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiationMegan Morisada, Paul E Clavijo, Ellen Moore, et al.Oncoimmunology|June 15, 2018
Nanocomplex-based <i>TP53</i> gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanismsEllen C Moore, Lillian Sun, Paul E Clavijo, et al.Communications Biology|December 21, 2021
Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypesCem Sievers, Yvette Robbins, Ke Bai, et al.Journal for Immunotherapy of Cancer|August 31, 2021
Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosisYvette Robbins, Jay Friedman, Paul E Clavijo, et al.Journal for Immunotherapy of Cancer|May 5, 2019
Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosisClint T Allen, Sunmin Lee, Scott M Norberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2019
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer ModelsSarah Greene, Yvette Robbins, Wojciech K Mydlarz, et al.Cancer Research|June 21, 2018
Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck CancersJialing Zhang, Tony Chen, Xinping Yang, et al.JCI Insight|April 5, 2019
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapyLillian Sun, Paul E Clavijo, Yvette Robbins, et al.Pageof 3